FEDweek

Hepatitis C Study Shows Promise

A study of experimental medications conducted by the Department of Veterans Affairs has shown significant cure rates for Hepatitis C. The test involved more than 17,000 veterans stricken with the disease. After treatment regimens of 12 weeks or longer,75 percent to 93 percent of the veterans showed no detectable signs of the disease in their blood. Furthermore, VA officials say the new treatment does not subject patients to side effects associated with interferon-related protocols, such as fever, fatigue and low blood counts. However, the new treatment is still expensive, VA said.